标题
Engineering opportunities in cancer immunotherapy
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 47, Pages 14467-14472
出版商
Proceedings of the National Academy of Sciences
发表日期
2015-11-24
DOI
10.1073/pnas.1508516112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications
- (2015) Haipeng Liu et al. BIOCONJUGATE CHEMISTRY
- Cell streak imaging cytometry for rare cell detection
- (2015) Joshua Balsam et al. BIOSENSORS & BIOELECTRONICS
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
- (2015) Laura Jeanbart et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Supramolecular peptide vaccines: tuning adaptive immunity
- (2015) Yi Wen et al. CURRENT OPINION IN IMMUNOLOGY
- Potential approaches for more successful dendritic cell-based immunotherapy
- (2015) Cheryl Lai-Lai Chiang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy
- (2015) Julien Valton et al. MOLECULAR THERAPY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Acoustic separation of circulating tumor cells
- (2015) Peng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
- (2015) Bonnie Huang et al. Science Translational Medicine
- Adoptive cellular therapy: A race to the finish line
- (2015) Carl H. June et al. Science Translational Medicine
- Programmable probiotics for detection of cancer in urine
- (2015) Tal Danino et al. Science Translational Medicine
- “In vitro” 3D models of tumor-immune system interaction
- (2014) Christian Hirt et al. ADVANCED DRUG DELIVERY REVIEWS
- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants
- (2014) Omar A. Ali et al. CANCER RESEARCH
- Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
- (2014) Tetsuya Honda et al. IMMUNITY
- Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
- (2014) Saar Gill et al. IMMUNOLOGICAL REVIEWS
- Lymph node stromal cells acquire peptide–MHCII complexes from dendritic cells and induce antigen-specific CD4+T cell tolerance
- (2014) Juan Dubrot et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Steady-State Antigen Scavenging, Cross-Presentation, and CD8+ T Cell Priming: A New Role for Lymphatic Endothelial Cells
- (2014) S. Hirosue et al. JOURNAL OF IMMUNOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics
- (2014) A. D. Warren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systems vaccinology: Probing humanity's diverse immune systems with vaccines
- (2014) B. Pulendran PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
- (2014) T. Pentcheva-Hoang et al. Cancer Immunology Research
- Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
- (2014) L. Jeanbart et al. Cancer Immunology Research
- Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles
- (2013) Armando Stano et al. BIOMATERIALS
- Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
- (2013) Susan N. Thomas et al. BIOMATERIALS
- Materials based tumor immunotherapy vaccines
- (2013) Weiwei Aileen Li et al. CURRENT OPINION IN IMMUNOLOGY
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Comparison of Vaccine-Induced Effector CD8 T Cell Responses Directed against Self- and Non-Self-Tumor Antigens: Implications for Cancer Immunotherapy
- (2013) S. R. Pedersen et al. JOURNAL OF IMMUNOLOGY
- Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
- (2013) Hiroyuki Suzuki et al. Journal of Translational Medicine
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Engineering synthetic vaccines using cues from natural immunity
- (2013) Darrell J. Irvine et al. NATURE MATERIALS
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- (2013) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice
- (2013) Iraklis C. Kourtis et al. PLoS One
- Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
- (2013) E. Ozkumur et al. Science Translational Medicine
- Quantitative Diagnosis of Malignant Pleural Effusions by Single-Cell Mechanophenotyping
- (2013) H. T. K. Tse et al. Science Translational Medicine
- Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
- (2013) Lana E. Kandalaft et al. OncoImmunology
- Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
- (2012) Matthias T. Stephan et al. BIOMATERIALS
- Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes
- (2012) Evan A. Scott et al. BIOMATERIALS
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- (2012) Hirokazu Matsushita et al. NATURE
- Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease
- (2012) Gabriel A Kwong et al. NATURE BIOTECHNOLOGY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers
- (2012) Rikke Sick Andersen et al. Nature Protocols
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering Approaches to Immunotherapy
- (2012) M. A. Swartz et al. Science Translational Medicine
- VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node Lymphatics
- (2012) Amanda W. Lund et al. Cell Reports
- Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
- (2011) J. L. Hood et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Therapeutic vaccination against human papilloma virus induced malignancies
- (2011) Sjoerd H van der Burg et al. CURRENT OPINION IN IMMUNOLOGY
- In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
- (2011) C. M. Jewell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
- (2010) Felix Moltzahn et al. CANCER RESEARCH
- Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
- (2010) Redas Trepiakas et al. CYTOTHERAPY
- Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions
- (2010) Anne L. Fletcher et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-infiltrating NY-ESO-1–specific CD8+T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
- (2010) Junko Matsuzaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
- (2010) Sachiko Hirosue et al. VACCINE
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
- (2009) O. A. Ali et al. Science Translational Medicine
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now